Congenital histiocytosis with central nervous system involvement and a novel PTPRJ::RASGRF1 fusion

Publication date

2026-06

Authors

Kemps, Paul G.
Bugiani, Marianna
Scheijde-Vermeulen, Marijn
Koudijs, Marco J.ISNI 0000000387366701
Emile, Jean François
Berkhemer, Olvert A.
Onland, Wes
Bos, Cor van den

Editors

Advisors

Supervisors

Document Type

Article

Collections

Open Access logo

License

cc_by

Abstract

Histiocytic neoplasms are rare diseases characterized by clonal expansions of cells with a macrophage or dendritic cell phenotype. They are driven by mutations activating the MAPK pathway and may involve diverse organs, including the central nervous system (CNS). We describe a newborn with congenital histiocytosis affecting the CNS, skin, lungs, lymph nodes, thyroid, fingernail, and soft tissues – including a tumor originating from the tongue obstructing the upper airway. Histopathology revealed an atypical histiocytosis with strong CD1a and variable Langerin expression; post-mortem transcriptome sequencing identified a novel PTPRJ::RASGRF1 fusion. This case expands the molecular landscape of histiocytic neoplasms, highlighting the value of comprehensive genomic profiling.

Keywords

Brain, CNS, ERK, Histiocytic neoplasm, Indeterminate dendritic cell histiocytosis, Langerhans cell histiocytosis, MAPK, Dentistry (miscellaneous), Biochemistry, Genetics and Molecular Biology (miscellaneous), Hematology, Oncology, Radiology Nuclear Medicine and imaging

Citation

Kemps, P G, Bugiani, M, Scheijde-Vermeulen, M A, Koudijs, M J, Emile, J F, Berkhemer, O A, Onland, W & Bos, C V D 2026, 'Congenital histiocytosis with central nervous system involvement and a novel PTPRJ::RASGRF1 fusion', EJC Paediatric Oncology, vol. 7, 100492. https://doi.org/10.1016/j.ejcped.2026.100492